Detalhe da pesquisa
1.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
N Engl J Med
; 390(6): 497-509, 2024 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38324483
2.
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.
Hepatology
; 78(4): 1223-1239, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37162151
3.
Rational combination therapy for NASH: Insights from clinical trials and error.
J Hepatol
; 78(5): 1073-1079, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603662
4.
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance.
J Hepatol
; 79(6): 1524-1541, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37730124
5.
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Clin Gastroenterol Hepatol
; 21(8): 2150-2166, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084928
6.
Clinical characteristics and management of patients with nonalcoholic steatohepatitis in a real-world setting: analysis of the Ipsos NASH therapy monitor database.
BMC Gastroenterol
; 23(1): 160, 2023 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208593
7.
Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD.
J Hepatol
; 76(5): 1030-1041, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35090960
8.
Preservation solutions for static cold storage in donation after circulatory death and donation after brain death liver transplantation in the United States.
Liver Transpl
; 28(9): 1454-1462, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35313073
9.
Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes.
Hepatology
; 73(4): 1464-1477, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32559317
10.
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
Semin Liver Dis
; 41(3): 225-234, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147036
11.
Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency.
Am J Transplant
; 21(3): 1039-1055, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32531107
12.
The demise of islet allotransplantation in the United States: A call for an urgent regulatory update.
Am J Transplant
; 21(4): 1365-1375, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251712
13.
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes.
Liver Transpl
; 27(7): 1019-1031, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619854
14.
Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation.
Hepatology
; 72(1): 315-329, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167613
15.
Knockout of sulfatase 2 is associated with decreased steatohepatitis and fibrosis in a mouse model of nonalcoholic fatty liver disease.
Am J Physiol Gastrointest Liver Physiol
; 319(3): G333-G344, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683952
16.
Nonalcoholic Steatohepatitis After Liver Transplantation.
Liver Transpl
; 26(1): 141-159, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610081
17.
Asian consensus recommendations on optimizing the diagnosis and initiation of treatment of hepatitis B virus infection in resource-limited settings.
J Viral Hepat
; 27(5): 466-475, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31785182
18.
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Hepatology
; 69(6): 2381-2395, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30706517
19.
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
J Hepatol
; 70(1): 133-141, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30291868
20.
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology
; 155(5): 1463-1473.e6, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30059671